View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
DOJ/DEA RIN: 1117-AB36 Publication ID: Fall 2014 
Title: ●Amendments to the Drug Enforcement Administration Hearing Regulations 
Abstract:

This rule proposes to amend the Drug Enforcement Administration (DEA) hearing regulations. In this rule the DEA proposes to amend its regulations that govern the procedures in administrative hearings to deny, revoke or suspend a DEA registration to handle controlled substances or listed chemicals. These regulations have not been amended since the inception of the regulations in 1971.

 
Agency: Department of Justice(DOJ)  Priority: Other Significant 
RIN Status: First time published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: Undetermined  Unfunded Mandates: No 
CFR Citation: Not Yet Determined     (To search for a specific CFR, visit the Code of Federal Regulations.)
Legal Authority: 21 USC 811    21 USC 812    21 USC 871(b)    21 USC 875    21 USC 958(d)    21 USC 965   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  03/00/2015 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
RIN Data Printed in the FR: No 
Agency Contact:
Demetra Ashley
Associate Deputy Assistant Administrator
Department of Justice
Drug Enforcement Administration
8701 Morrissette Drive,
Springfield, VA 22152
Phone:202 307-7165